[
  {
    "ts": null,
    "headline": "Amgen (AMGN) Falls 5.8% as Novo Nordisk Hammers Its Weight Loss Drug Trial",
    "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the These 10 Stocks Took A Shocking Fall. Amgen Inc. extended its losing streak to a fourth straight day on Monday, dropping 5.84 percent to close at $272.44 apiece as investors sold off positions despite positive results from its weight loss drug trial, after Novo Nordisk—maker of the blockbuster Wegovy […]",
    "url": "https://finnhub.io/api/news?id=fbb19cfe72fccfd084b632dff08d09223596c17ea01de25851e4e643c322d2cb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750788430,
      "headline": "Amgen (AMGN) Falls 5.8% as Novo Nordisk Hammers Its Weight Loss Drug Trial",
      "id": 135511513,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the These 10 Stocks Took A Shocking Fall. Amgen Inc. extended its losing streak to a fourth straight day on Monday, dropping 5.84 percent to close at $272.44 apiece as investors sold off positions despite positive results from its weight loss drug trial, after Novo Nordisk—maker of the blockbuster Wegovy […]",
      "url": "https://finnhub.io/api/news?id=fbb19cfe72fccfd084b632dff08d09223596c17ea01de25851e4e643c322d2cb"
    }
  },
  {
    "ts": null,
    "headline": "Dow's nearly 600-point rally highlighted by gains in shares of Salesforce, American Express",
    "summary": "Dow's nearly 600-point rally highlighted by gains in shares of Salesforce, American Express",
    "url": "https://finnhub.io/api/news?id=ea6f48831ddd4b397673a19a5991ffe7aafaf0fae3104856e0309e54a4c9f25d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750779720,
      "headline": "Dow's nearly 600-point rally highlighted by gains in shares of Salesforce, American Express",
      "id": 135538872,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Dow's nearly 600-point rally highlighted by gains in shares of Salesforce, American Express",
      "url": "https://finnhub.io/api/news?id=ea6f48831ddd4b397673a19a5991ffe7aafaf0fae3104856e0309e54a4c9f25d"
    }
  },
  {
    "ts": null,
    "headline": "New Amgen obesity drug data disappoint Wall Street",
    "summary": "Full Phase 2 study results showed side effects that led people to stop treatment with MariTide, as well as weight loss effects that weren’t as strong as previously reported.",
    "url": "https://finnhub.io/api/news?id=5d706259dd211678a25257393b4e0f70ccbf98d3e0fa4f75cf3d63a002102af2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750765920,
      "headline": "New Amgen obesity drug data disappoint Wall Street",
      "id": 135508743,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Full Phase 2 study results showed side effects that led people to stop treatment with MariTide, as well as weight loss effects that weren’t as strong as previously reported.",
      "url": "https://finnhub.io/api/news?id=5d706259dd211678a25257393b4e0f70ccbf98d3e0fa4f75cf3d63a002102af2"
    }
  },
  {
    "ts": null,
    "headline": "2 Small-Cap Stocks Under $10 to Buy With Big Potential",
    "summary": "These high-risk, high-reward small-cap biotech stocks deserve a second look.",
    "url": "https://finnhub.io/api/news?id=b59be0ee84a48f0451fabfdd80e82b49f7a674b22821937cef3874fbf325f1c5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750764602,
      "headline": "2 Small-Cap Stocks Under $10 to Buy With Big Potential",
      "id": 135506525,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "These high-risk, high-reward small-cap biotech stocks deserve a second look.",
      "url": "https://finnhub.io/api/news?id=b59be0ee84a48f0451fabfdd80e82b49f7a674b22821937cef3874fbf325f1c5"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. (AMGN) Presents at Special Call (IR Call) Conference Transcript",
    "summary": "Amgen Inc. (NASDAQ:AMGN) Special Call (IR Call) Conference June 23, 2025 5:30 PM ETCompany ParticipantsJustin Claeys - Vice President of Investor Relations...",
    "url": "https://finnhub.io/api/news?id=435bb63de33d0cdcc7f620816c16da05241bb1f47595479bd8589f51742e35c2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750729491,
      "headline": "Amgen Inc. (AMGN) Presents at Special Call (IR Call) Conference Transcript",
      "id": 135489076,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Amgen Inc. (NASDAQ:AMGN) Special Call (IR Call) Conference June 23, 2025 5:30 PM ETCompany ParticipantsJustin Claeys - Vice President of Investor Relations...",
      "url": "https://finnhub.io/api/news?id=435bb63de33d0cdcc7f620816c16da05241bb1f47595479bd8589f51742e35c2"
    }
  }
]